Lung Diseases Cies Search Engine [selected websites]

Loading

Blog Archive

Feb 13, 2008

GlaxoSmithKline and TB Alliance, Tuberculosis Drug Discovery Program

January 24, 2008 - GlaxoSmithKline (GSK) and the Global Alliance for TB Drug Development (TB Alliance) have renewed their joint research program with the goal to improve the treatment of tuberculosis (TB), which is caused by the bacillus Mycobacterium tuberculosis (M.tb). The research collaboration, initiated in 2004, currently includes a portfolio of early projects which may ultimately yield new medicines that attack M.tb, including drug-resistance strains... TB Alliance's Press Release-